Physical Medicine & Rehabilitation Doctors in Kansas City, KS Accepting Medicare

13 Physical Medicine & Rehabilitation doctors found. Showing 1 - 13

Dr. Tiffany Williams, MD Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 3901 Rainbow Blvd, Kansas City, KS 66160 Phone: 913-588-6777

Dr. Lisa Ann Mcpeak, M.D. Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 3901 Rainbow Blvd, G018 Murphy, Mailstop 1046, Kansas City, KS 66160 Phone: 913-588-6796    Fax: 913-588-6765

Dr. Sarah Maria Eickmeyer, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 3901 Rainbow Blvd, Physical Medicine And Rehabilitation, Kansas City, KS 66160 Phone: 913-588-6944    Fax: 913-588-6765

Dr. George Varghese, M.D. Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 3901 Rainbow Blvd, G018 Murphy Mailstop 1046, Kansas City, KS 66160 Phone: 913-588-6944    Fax: 913-588-6765

Namrata Abhishek Raut, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 3901 Rainbow Blvd, Kansas City, KS 66160 Phone: 913-588-6944    Fax: 913-588-6765

Alexandra Nielsen Arickx, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 3901 Rainbow Blvd, Kansas City, KS 66160 Phone: 913-588-6796

Raelene Michelle Knolla, D.O. Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 3901 Rainbow Blvd, Ms 1046, Kansas City, KS 66160 Phone: 913-588-6777    Fax: 913-588-6765

Mojgan H Saber, MD Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 3901 Rainbow Blvd, Kansas City, KS 66160 Phone: 818-694-9485

Dr. James Patrick Mclean, MD Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: Rehabilitation Medicine, Mail Stop 1046, K.u. Medical Center, 3901, Kansas City, KS 66160 Phone: 913-588-6944

Shawn M Mcgargill, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 4000 Cambridge St # Ms 1046, Kansas City, KS 66160 Phone: 913-588-9900    Fax: 913-588-6765

Dr. Alejandra Camacho-soto, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 4000 Cambridge St, Kansas City, KS 66160 Phone: 913-588-6944    Fax: 913-588-6765

Sivakoti R Katta, MD Physical Medicine & Rehabilitation Medicare: May Accept Medicare Assignments Practice Location: 8919 Parallel Pkwy Ste 215, Kansas City, KS 66112 Phone: 913-499-8091    Fax: 913-499-7440

Gregory Herman, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 3901 Rainbow Blvd, Kansas City, KS 66160 Phone: 913-588-6777

News Archive

MorphoSys unveils next-generation antibody technology Ylanthia

MorphoSys AG today unveiled its next-generation antibody technology Ylanthia®. The technology was presented to an audience of specialists at the 2011 Antibody Engineering and Antibody Therapeutics Conference in San Diego. MorphoSys expects Ylanthia to set new standards for therapeutic antibody generation in the pharmaceutical industry over the next decade and beyond. Commercial application will commence in 2012.

MUSC receives $16.5 million NIH funding to open two new digestive disease research centers

This spring marked a seismic shift for digestive and liver disease research at the Medical University of South Carolina with the award of more than $16.5 million in National Institutes of Health funding to open two new tightly integrated centers.

Curis reports topline results from GDC-0449 Phase II clinical trial for metastatic colorectal cancer

Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced topline results from a Phase II clinical trial conducted by Roche and Genentech, Curis' collaborator and a wholly owned member of the Roche Group, of GDC-0449, a first-in-class Hedgehog pathway inhibitor. GDC-0449 was tested in combination with Avastin® (bevacizumab) and FOLFOX or FOLFIRI chemotherapy in first-line metastatic colorectal cancer patients.

Genotoxic bacteria in the digestive tract

Escherichia coli is a commensal bacterium, which lives peacefully in our digestive tract. However, certain strains are pathogenic and are frequently incriminated in a broad spectrum of infections, affecting both farmed animals and humans (diarrhoea, urinary tract infections, food poisoning, septicaemia, neonatal meningitis, etc.).

NewYork-Presbyterian /Columbia sets up new Myelodysplastic Syndromes Center

NewYork-Presbyterian Hospital/Columbia University Medical Center has established a new center devoted to research and treatment of pre-leukemia blood disorders. Known as the Myelodysplastic Syndromes Center, it is one of the largest programs of its kind in the nation.

Read more Medical News

› Verified 2 days ago